Skip to main content
Back to MassChallenge

MassChallenge's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by MassChallenge. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$14.5M

Therapeutics Portfolio Companies (3)

Export
BiotechnologyLife ScienceTherapeutics

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

Ness Ziona, Israel
September 2024
$10.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareTherapeuticsWellness

Canopie offers a digital platform that addresses symptoms of maternal depression and anxiety.

Washington, United States
September 2024
$3.7M
Seed

Founder Contacts

19,000+ verified contacts

3D PrintingBiotechnologyLife ScienceMedicalTherapeutics

TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.

Bellinzona, Switzerland
March 2024
$800K
Pre-Seed

Founder Contacts

19,000+ verified contacts

Explore MassChallenge's Full Portfolio

View all companies funded by MassChallenge across every industry and funding stage.

View Full MassChallenge Portfolio